Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Friday, August 5, 2011

Boston to host 2012 AdvaMed medical technology event

By Michelle Lang

AdvaMed, a medical technology event regularly held in Washington D.C. since 2007, is branching out in 2012 to Boston – the first city outside of the nation’s capitol to host the event.

AdvaMed is an annual conference to showcase medical technology and devices in the industry. The 2011 show, to be held in DC from September 26 to September 28, is expected to draw 1,900 attendees from 30 states and 20 countries. AdvaMed 2012 will be hosted at the Boston Convention and Exhibition Center from October 1 to October 3, 2012.

“Choosing Boston was an easy decision, because this metropolitan area is so critical to the health of the medical technology industry and the life-saving, life-changing products it makes,” Kenneth Mendez, senior executive vice president and chief administrative officer of AdvaMed, the Advanced Medical Technology Association, said in a statement.

A news release noted that Boston’s AdvaMed hosting news was announced at Fenway Park with a gathering of medical device industry players.





 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

Should RI officials have approved the $75M loan to 38 Studios?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.